科研
教育
解决方案
登录
CN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Pathology,
Department of Physiology,
Development and Neuroscience,
Centre for Trophoblast Research,
Department of Physiology, Development and Neuroscience
Jyothi Jayaraman has not added Biography.
If you are Jyothi Jayaraman and would like to personalize this page please email our Author Liaison for assistance.
Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors.
Genome research Oct, 2012 | Pubmed ID: 22948769
Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population.
Immunogenetics Nov, 2013 | Pubmed ID: 23974321
Killer-cell Immunoglobulin-like Receptor gene linkage and copy number variation analysis by droplet digital PCR.
Genome medicine , 2014 | Pubmed ID: 24597950
A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.
BMC genomics Apr, 2014 | Pubmed ID: 24720548
A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia.
Proceedings of the National Academy of Sciences of the United States of America Jan, 2015 | Pubmed ID: 25561558
Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.
American journal of human genetics Aug, 2016 | Pubmed ID: 27486779
Estimating KIR Haplotype Frequencies on a Cohort of 10,000 Individuals: A Comprehensive Study on Population Variations, Typing Resolutions, and Reference Haplotypes.
PloS one , 2016 | Pubmed ID: 27723813
Novel KIR genotypes and gene copy number variations in northeastern Thais.
Immunology 03, 2018 | Pubmed ID: 28950036
High-Resolution Genetic and Phenotypic Analysis of KIR2DL1 Alleles and Their Association with Pre-Eclampsia.
Journal of immunology (Baltimore, Md. : 1950) Nov, 2018 | Pubmed ID: 30249807
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8 T cell-mediated control of HIV-1, HCV, and HTLV-1.
Science immunology Nov, 2018 | Pubmed ID: 30413420
University of Cambridge
University of Cambridge School of Medicine, NIHR Cambridge Biomedical Research Centre
Jyothi Jayaraman1,2,3,4,
Vitalina Kirgizova1,
Da Di1,5,
Christopher Johnson1,6,
Wei Jiang1,7,
James A. Traherne1
1Department of Pathology, University of Cambridge,
2Department of Physiology, Development and Neuroscience, University of Cambridge,
3Department of Obstetrics and Gynaecology, University of Cambridge School of Medicine, NIHR Cambridge Biomedical Research Centre,
4Centre for Trophoblast Research, University of Cambridge,
5Department of Genetics & Evolution, University of Geneva,
6, Royal Papworth Hospital,
7Department of Plant Sciences, University of Cambridge
政策
使用条款
隐私
联系我们
向图书馆推荐
JoVE 新闻简报
JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
发表
图书馆员
访问权限
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。